Discover 3,132 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,132
Active & Responsive
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
for
Lower Extremity Acute Limb Ischemia, LE ALI
Location: Houston TX, Dallas TX, Plano TX, Jackson TN,
Sponsor: Penumbra Inc.
Sex: All
Age: 18+
Code: NCT06747117
Recruiting
Active & Responsive
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
for
Peanut Allergies
Location: Houston TX, Dallas TX, Little Rock AR, Tampa FL,
Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block
for
Heart Block Complete, Heart Block Second Degree
Location: Houston TX, Kansas City KS, Saint Petersburg FL,
Sponsor: The Hospital for Sick Children
Sex: Female
Age: 16 - 50
Code: NCT04559425
Recruiting
Active & Responsive
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
for
Spinal Muscular Atrophy (SMA)
Location: Houston TX, Flower Mound TX, Little Rock AR,
Sponsor: argenx
Sex: All
Age: 5 - 17
Code: NCT07287982
Phase 2, Recruiting
Active & Responsive
A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)
for
Cytomegalovirus Prophylaxis
Location: Houston TX, Birmingham AL, Atlanta GA, Aurora CO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT07199465
Phase 1, Recruiting
Active & Responsive
Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Children
for
Functional Abdominal Pain Disorders,
Location: Houston TX, Austin TX
Sponsor: Baylor College of Medicine
Sex: All
Age: 7 - 12
Code: NCT07222943
Recruiting
Active & Responsive
Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
for
Osteosarcoma Recurrent, Osteosarcoma in Children,
Location: Houston TX, Atlanta GA
Sponsor: Emory University
Sex: All
Age: 1 - 30
Code: NCT07144254
Phase 1, Recruiting
Active & Responsive
High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
Location: Houston TX, Dallas TX, Little Rock AR, Kansas City MO,
Sponsor: Mezzion Pharma Co. Ltd
Sex: All
Age: 12 - 18
Code: NCT05918211
Phase 3, Recruiting
Active & Responsive
Danon Disease Natural History Study
for
Danon Disease
Location: Houston TX, Dallas TX, St Louis MO, Gainesville FL,
Sponsor: Rocket Pharmaceuticals Inc.
Sex: All
Age: 8+
Code: NCT06214507
Recruiting
Active & Responsive
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Houston TX, Little Rock AR, St Louis MO, Atlanta GA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 2+
Code: NCT06789913
Phase 2, Recruiting
Active & Responsive
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 3+
Code: NCT02523118
Recruiting
Active & Responsive
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)